Cortex gains two US patents for AMPAKINE compounds
Linkedin

Cortex gains two US patents for AMPAKINE compounds

London : United Kingdom | Mar 14, 2012 at 1:57 AM PDT
Source: Pharmaceutical Industry News
XX XX
Views: Pending
 
CX2007 and CX2076, which exhibit a long duration of action and pharmacokinetic properties through August 2028. The company received a composition-of-matter patent and a divisional patent covering methods of use, including the treatment for a range of breathing disorders. FULL ARTICLE AT Pharmaceutical Industry News
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.